Evidence map›Paper›PMID 30637731›Full record

ArticleJournal of cellular physiology2019

Trpm2 enhances physiological bioenergetics and protects against pathological oxidative cardiac injury: Role of Pyk2 phosphorylation.

Barbara A Miller, JuFang Wang, Jianliang Song, Xue-Qian Zhang, Iwona Hirschler-Laszkiewicz, Santhanam Shanmughapriya, Dhanendra Tomar, Sudasan Rajan, Arthur M Feldman, Muniswamy Madesh and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Role of the LRP1-pPyk2-MMP9 pathway in hyperoxia-induced lung injury in neonatal rats.Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2021
    Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Barbara A MillerDepartment of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
JuFang WangCenter for Translational Medicine, Department of Pharmacology, Lewis Katz School of Medicine of Temple University, Philadelphia, Pennsylvania.
Jianliang SongCenter for Translational Medicine, Department of Pharmacology, Lewis Katz School of Medicine of Temple University, Philadelphia, Pennsylvania.
Xue-Qian ZhangCenter for Translational Medicine, Department of Pharmacology, Lewis Katz School of Medicine of Temple University, Philadelphia, Pennsylvania.
Iwona Hirschler-LaszkiewiczDepartment of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
Santhanam ShanmughapriyaCenter for Translational Medicine, Department of Pharmacology, Lewis Katz School of Medicine of Temple University, Philadelphia, Pennsylvania.
Dhanendra TomarCenter for Translational Medicine, Department of Pharmacology, Lewis Katz School of Medicine of Temple University, Philadelphia, Pennsylvania.
Sudasan RajanCenter for Translational Medicine, Department of Pharmacology, Lewis Katz School of Medicine of Temple University, Philadelphia, Pennsylvania.
Arthur M FeldmanDepartment of Medicine, Lewis Katz School of Medicine of Temple University, Philadelphia, Pennsylvania.ORCID http://orcid.org/0000-0001-8351-9569
Muniswamy MadeshCenter for Translational Medicine, Department of Pharmacology, Lewis Katz School of Medicine of Temple University, Philadelphia, Pennsylvania.
Shey-Shing SheuCenter for Translational Medicine, Department of Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Joseph Y CheungCenter for Translational Medicine, Department of Pharmacology, Lewis Katz School of Medicine of Temple University, Philadelphia, Pennsylvania.ORCID http://orcid.org/0000-0002-8024-9177
Temple University · USPennsylvania State University · USThe University of Texas Health Science Center at San Antonio · USThomas Jefferson University · US

Funding

Targeted Cancer Therapeutics and Heart Failure: Mechanisms and Post-injury RepairP01HL091799 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI HOUSER, STEVEN R · 2008 to 2018
$23.1M
Ca2+ and ROS Crosstalk Signaling in Cardiac MitochondriaR01HL093671 · NHLBI · UNIVERSITY OF ROCHESTER · PI SHEU, SHEY-SHING · 2010 to 2023
$5.1M
Coordination of Pathophysiologic Endothelial Cell Signaling by ROSR01HL086699 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI MUNISWAMY, MADESH · 2008 to 2018
$4.3M
Mitochondria-SR Tethering: Its Role in Cardiac Bioenergetics and Ca2+ DynamicsR01HL122124 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI CSORDAS, GYORGY, SHEU, SHEY-SHING · 2014 to 2025
$4.0M
Involvement of BAG3 in HIV-1 induced cardiomyopathyR01HL123093 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI CHEUNG, JOSEPH Y, FELDMAN, ARTHUR M · 2014 to 2018
$3.7M
Spectral revelations of mitochondrial Ca2+ flux interactomeR01GM109882 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI MUNISWAMY, MADESH · 2014 to 2022
$3.3M
SIGNAL TRANSDUCTION MECHANISMS OF ERYTHROPOIETINR01DK046778 · NIDDK · WEIS CENTER FOR RESEARCH-GEISINGER CLINC · PI MILLER, BARBARA A. · 1994 to 2011
$2.6M
Dynamin-Related Protein Drp1 Regulates Cardiac Excitation-Contraction-Bioenergetics CouplingR01HL137266 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI SHEU, SHEY-SHING, WANG, WANG · 2018 to 2021
$2.5M
Methylene blue as an antidote against hydrogen sulfide intoxicationU01NS097162 · NINDS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI HAOUZI, PHILIPPE A · 2016 to 2018
$2.2M
Trpm2: A novel target in Onco-cardiologyR01HL137426 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI CHEUNG, JOSEPH Y · 2017 to 2020
$2.2M
Inhibition of MCUR1-MCU mediated mitochondrial Ca2+ uptake prevents I/R injuryR01HL119306 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI MUNISWAMY, MADESH · 2014 to 2017
$1.6M
TRPM2, Mitochondria, and Cell SurvivalR01GM117014 · NIGMS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI MILLER, BARBARA A. · 2016 to 2019
$1.2M
National Heart, Lung, and Blood Institute PO1-HL91799National Heart, Lung, and Blood Institute RO1-HL093671National Heart, Lung, and Blood Institute RO1-HL122124National Heart, Lung, and Blood Institute RO1-HL123093National Heart, Lung, and Blood Institute RO1-HL137266National Heart, Lung, and Blood Institute RO1-HL137426National Heart, Lung, and Blood Institute RO1-HL86699National Institute of Diabetes and Digestive and Kidney Diseases RO1-DK46778National Institute of General Medical Sciences R01-GM117014National Institute of Neurological Disorders and Stroke R21-NS098991National Institute of Neurological Disorders and Stroke UO1-NS097162NHLBI NIH HHS P01 HL091799NHLBI NIH HHS R01 HL086699NHLBI NIH HHS R01 HL093671NHLBI NIH HHS R01 HL119306NHLBI NIH HHS R01 HL122124NHLBI NIH HHS R01 HL123093NHLBI NIH HHS R01 HL137266NHLBI NIH HHS R01 HL137426NIDDK NIH HHS R01 DK046778NIGMS NIH HHS R01 GM109882NIGMS NIH HHS R01 GM117014NINDS NIH HHS R21 NS098991NINDS NIH HHS U01 NS097162
6 · The paper itself

Abstract

The mechanisms by which Trpm2 channels enhance mitochondrial bioenergetics and protect against oxidative stress-induced cardiac injury remain unclear. Here, the role of proline-rich tyrosine kinase 2 (Pyk2) in Trpm2 signaling is explored. Activation of Trpm2 in adult myocytes with H

Indexed as

hypoxia-reoxygenationischemic cardiomyopathymitochondrial oxidantsoxidative injuryvoltage-independent Ca2+ channels

Identifiers

PMID30637731
PMCPMC6626587
OpenAlexW2909996398

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.